Epigral Limited
NSE: EPIGRAL · Specialty Chemicals · sector
₹885.50NSE close 2026-10-26
Key numbers
Market cap₹3,820 cr
Price₹885.50
52w high / low₹1,730 / ₹807
P/E14.1xSector median 22.6x
P/B1.7xSector median 2.6x
Book value₹514.9
Dividend yield0.48%Sector median 0.60%
ROE13.1%Sector median 10.6%
ROCE15.2%Sector median 12.9%
OPM22.2%Sector median 12.1%
Debt / equity0.25xSector median 0.18x
EV/EBITDA7.5xSector median 15.1x
Interest cover7.6x
Current ratio1.16x
Sales growth 3y+4.9%Sector median +5.0%
Profit growth 3y-2.0%Sector median +0.9%
PEG–
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 107 companies in Specialty Chemicals (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹5 cr vs borrowings ₹563 cr (FY26): borrowings are higher by ₹558 cr.
- Operating profit covered interest 7.6x in the last 12 months.
- No promoter shares are pledged.
- Operating cash flow was below net profit in 0 of the last 5 years.
- Revenue was higher than a year earlier in 2 of the last 4 quarters.
- Other income was 4% of net profit in the last 12 months.
- Debtor days went from 34 (FY24) to 60 (FY26).
- Dividend paid in 4 of the last 5 financial years.
- Price ₹885.50 on 2026-10-26: -48.8% from the 52-week high, +9.7% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹2,344.35 · low ₹818.50
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 626 | 645 | 628 | 607 | 587 | 597 | 736 | 705 |
| EBITDA | 178 | 183 | 173 | 163 | 132 | 103 | 169 | 179 |
| OPM % | 28.5% | 28.3% | 27.6% | 26.9% | 22.5% | 17.2% | 22.9% | 25.4% |
| Other income | 6 | 4 | 3 | 8 | 2 | 6 | -1 | 4 |
| Net profit | 81 | 104 | 87 | 161 | 51 | 39 | 81 | 100 |
| EPS (₹) | 19.57 | 24.25 | 20.14 | 37.25 | 11.87 | 9.07 | 18.76 | 23.12 |
| Revenue YoY | -6.2% | -7.5% | +17.3% | +16.3% | ||||
| Profit YoY | -37.0% | -62.3% | -6.8% | -37.9% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 1,551 | 2,188 | 1,929 | 2,550 | 2,527 | 2,626 |
| EBITDA | 509 | 689 | 481 | 711 | 567 | 583 |
| Net profit | 253 | 353 | 196 | 358 | 332 | 271 |
| EPS (₹) | 60.84 | 85.03 | 47.13 | 84.68 | 76.95 | 62.82 |
| Revenue growth | +41.1% | -11.8% | +32.2% | -0.9% | +4.8% | |
| Profit growth | +39.8% | -44.6% | +82.7% | -7.2% | -37.3% | |
| Dividend / share (₹) | – | 2.50 | 2.50 | 7.50 | 3.50 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +4.9% | – | +4.8% |
| Net profit | -2.1% | – | -37.3% |
| EPS | -3.3% | – | – |
| Share price | – | -33.5% (2y) | -44.9% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 1,069 | 1,254 | 1,905 | 2,221 |
| Borrowings | – | 876 | 963 | 585 | 563 |
| Cash & equivalents | – | 15 | 7 | 99 | 5 |
| Total assets | – | 2,432 | 2,794 | 3,152 | 3,505 |
| Fixed assets | – | 1,779 | 1,745 | 2,219 | 2,102 |
| Capital work in progress | – | 158 | 483 | 64 | 451 |
| Investments | – | 0 | 0 | 0 | 0 |
| Receivables | – | 166 | 179 | 232 | 417 |
| Inventory | – | 212 | 263 | 388 | 349 |
| Payables | – | 110 | 165 | 186 | 260 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 284 | 626 | 398 | 441 | 436 |
| Cash from investing | -455 | -437 | -401 | -262 | -355 |
| Cash from financing | 195 | -200 | -8 | -164 | -94 |
| Capex | 456 | 416 | 398 | 195 | 394 |
| Free cash flow | -172 | 210 | -1 | 246 | 41 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 33.0% | 15.6% | 18.8% | 14.9% |
| ROCE % | – | 30.2% | 16.4% | 23.8% | 14.9% |
| Debtor days | – | 28 | 34 | 33 | 60 |
| Inventory days | – | 69 | 90 | 105 | 89 |
| Payable days | – | 36 | 57 | 50 | 66 |
| Cash conversion cycle (days) | – | 61 | 67 | 88 | 83 |
| Working capital days | – | -38 | -53 | 40 | 17 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 68.83% |
| FIIs | 0.99% |
| DIIs | 4.90% |
| of which Mutual funds | 4.87% |
| Government | 0.02% |
| Public (non-institutions) | 25.26% |
| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 68.94% | 68.95% | 68.83% | 68.83% | 68.83% | 68.83% | 68.83% | 68.83% |
| Promoter group | % |
|---|---|
| Ashishbhai Natawarlal Soparkar | 14.65% |
| Patel Natwarlal Meghjibhai | 9.68% |
| Jayantibhai Meghjibhai Patel | 8.29% |
| Rameshbhai Meghajibhai Patel | 6.79% |
| Maulik Jayantibhai Patel | 5.19% |
| Patel Ankit Natwarlal | 4.44% |
| Anandbhai Ishwarbhai Patel | 4.21% |
| Taraben Jayantilal Patel | 2.34% |
| Patel Karana Rameshbhai | 1.68% |
| Kalpana Rameshbhai Patel | 1.28% |
| Patel Natubhai Meghjibhai (HUF) | 1.13% |
| Disha Kevatkumar Vanani | 1.13% |
| Vaishakhi Dhiren Goyal | 0.97% |
| Bhartiben Natubhai Patel | 0.97% |
| Chintan Anandbhai Patel | 0.95% |
| Public holders above 1% | % |
|---|---|
| Bandhan Small Cap Fund | 3.38% |
| VLS Finance Ltd | 1.91% |
| HSBC Mutual Fund - HSBC Value Fund | 1.50% |
76,384 shareholders. Pledged: 0.00% of promoter shares.
Peers in Specialty Chemicals
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| PIDILITIND | ₹1,50,431 cr | 56.8x | 13.9x | 25.7% | 33.4% | 24.5% | +7.4% | 1.01% |
| FLUOROCHEM | ₹46,168 cr | 75.4x | 5.9x | 8.1% | 10.0% | 25.6% | -4.2% | 0.07% |
| NAVINFLUOR | ₹39,306 cr | 49.7x | 9.9x | 23.9% | 22.2% | 33.7% | +16.8% | 0.18% |
| DEEPAKNTR | ₹19,676 cr | 25.1x | 3.4x | 14.0% | 15.3% | 15.4% | -0.4% | 0.52% |
| AETHER | ₹19,529 cr | 82.8x | 8.0x | 10.1% | 11.4% | 30.9% | +21.2% | – |
| ATUL | ₹15,762 cr | 19.8x | 2.5x | 11.9% | 16.9% | 17.9% | +7.9% | 0.47% |
| AARTIIND | ₹15,539 cr | 29.3x | 2.6x | 9.2% | 8.0% | 14.9% | +7.8% | 0.24% |
| FINEORG | ₹15,328 cr | 35.0x | 5.8x | 17.7% | 21.3% | 21.7% | -7.8% | 0.22% |
| BASF | ₹13,174 cr | 20.5x | 3.3x | 16.9% | 22.0% | 5.9% | +3.1% | 0.66% |
| EPIGRAL | ₹3,820 cr | 14.1x | 1.7x | 13.1% | 15.2% | 22.2% | +4.9% | 0.48% |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-06-01 | Dividend | Dividend - Rs 5 Per Share |
| 2025-06-20 | Dividend | Dividend - Rs 3.50 Per Share |
| 2025-02-07 | Dividend | Interim Dividend - Rs 2.50 Per Share |
| 2024-07-02 | Dividend | Annual General Meeting/Dividend - Rs 5 Per Share |
| 2023-06-20 | Dividend | Dividend - Rs 2.50 Per Share |
| 2023-06-20 | Other | Annual General Meeting |
| 2023-02-01 | Dividend | Interim Dividend - Rs 2.50 Per Share |
| 2022-06-17 | Other | Annual General Meeting |
| 2021-09-15 | Other | Annual General Meeting |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Announcements NSE filings
- BRSR FY26
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
- Manufacturing and Selling of Chemicals including Derivates and Specialty Chemicals: Manufacturing and Selling of Chemicals including Derivates and Specialty Chemicals
| Sector | Commodities |
| Industry | Specialty Chemicals |
| Sub-industry | Specialty Chemicals |
| Symbol | EPIGRAL |
| BSE code | 543332 |
| ISIN | INE071N01016 |
| Face value | ₹10.0 |
| Incorporated | 2007-09-11 |
| Website | www.epigral.com |
| Plants (India / abroad) | 1 / 0 |
From the company's filings (BRSR FY26).
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.